Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Anbio Biotechnology (NNNN) had Current Liabilities of $1.73M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$8.19M |
|
$2.37M |
|
$2.30M |
|
$5.89M |
|
$6.19M |
|
$2.00M |
|
$0.38M |
|
$2.37M |
|
$2.37M |
|
$2.37M |
|
$2.37M |
|
$2.37M |
|
$2.37M |
|
$2.00M |
|
$2.00M |
|
42.29M |
|
42.29M |
|
$0.06 |
|
$0.06 |
|
| Balance Sheet Financials | |
$18.53M |
|
-- |
|
$0.39M |
|
$18.92M |
|
|
Current Liabilities |
$1.73M |
-- |
|
-- |
|
$1.73M |
|
$17.19M |
|
$17.19M |
|
$17.19M |
|
142.29M |
|
| Cash Flow Statement Financials | |
$2.08M |
|
$0.34M |
|
$-0.34M |
|
$9.69M |
|
$11.76M |
|
$2.07M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
71.90% |
|
24.38% |
|
24.38% |
|
24.38% |
|
28.99% |
|
28.99% |
|
$2.08M |
|
-- |
|
-- |
|
-- |
|
0.43 |
|
-- |
|
7.69 |
|
47.48 |
|
13.80% |
|
13.80% |
|
12.54% |
|
13.80% |
|
$0.12 |
|
$0.05 |
|
$0.05 |
|